amifostine anhydrous has been researched along with Venous Thrombosis in 1 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Venous Thrombosis: The formation or presence of a blood clot (THROMBUS) within a vein.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hofmann, WK | 1 |
| Seipelt, G | 1 |
| Ottmann, OG | 1 |
| Kalina, U | 1 |
| Koschmieder, S | 1 |
| Brücher, J | 1 |
| Frickhofen, N | 1 |
| Klausmann, M | 1 |
| Mitrou, PS | 1 |
| Hoelzer, D | 1 |
1 other study available for amifostine anhydrous and Venous Thrombosis
| Article | Year |
|---|---|
Effect of treatment with amifostine used as a single agent in patients with refractory anemia on clinical outcome and serum tumor necrosis factor alpha levels.
Topics: Aged; Amifostine; Anemia, Refractory; Anemia, Refractory, with Excess of Blasts; Drug Administration | 2000 |